Comparison of Empagliflozin-Linagliptin with Empagliflozin- Metformin Combination Therapy in Assessing Cardiovascular Profile and Anemia in Type 2 Diabetic Patients. J. Bahria Univ. Med. Dent. Coll. 2025;15(04):282-287. doi:10.51985/JBUMDC2025572